DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 88 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 7.52 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $7,666,173 | -2.2% | 487,360 | +0.2% | 0.00% | 0.0% |
Q4 2023 | $7,842,180 | +142.1% | 486,186 | +90.9% | 0.00% | +100.0% |
Q3 2023 | $3,239,415 | +23.5% | 254,671 | +36.7% | 0.00% | +100.0% |
Q2 2023 | $2,622,203 | -5.9% | 186,236 | +3.3% | 0.00% | -50.0% |
Q1 2023 | $2,785,203 | +682.1% | 180,272 | +729.7% | 0.00% | – |
Q4 2022 | $356,122 | -5.5% | 21,728 | +6.5% | 0.00% | – |
Q3 2022 | $377,000 | -1.0% | 20,404 | -29.6% | 0.00% | – |
Q2 2022 | $381,000 | -57.5% | 28,963 | -70.0% | 0.00% | – |
Q1 2022 | $896,000 | +158.2% | 96,628 | +172.5% | 0.00% | – |
Q4 2021 | $347,000 | -93.2% | 35,456 | -76.3% | 0.00% | -100.0% |
Q3 2021 | $5,089,000 | -8.1% | 149,773 | -1.0% | 0.00% | -33.3% |
Q2 2021 | $5,536,000 | -31.1% | 151,220 | -15.7% | 0.00% | -25.0% |
Q1 2021 | $8,040,000 | -22.3% | 179,314 | -1.1% | 0.00% | -33.3% |
Q4 2020 | $10,349,000 | -18.8% | 181,333 | -27.0% | 0.01% | -33.3% |
Q3 2020 | $12,748,000 | +19.9% | 248,500 | +39.6% | 0.01% | +12.5% |
Q2 2020 | $10,634,000 | +89.4% | 178,071 | +30.5% | 0.01% | +60.0% |
Q1 2020 | $5,616,000 | -45.1% | 136,404 | -17.0% | 0.01% | -28.6% |
Q4 2019 | $10,232,000 | +29.8% | 164,431 | -29.2% | 0.01% | +40.0% |
Q3 2019 | $7,884,000 | +254.7% | 232,378 | +135.6% | 0.01% | +400.0% |
Q2 2019 | $2,223,000 | -1.2% | 98,629 | +1.6% | 0.00% | 0.0% |
Q1 2019 | $2,251,000 | +10.6% | 97,098 | +0.1% | 0.00% | 0.0% |
Q4 2018 | $2,036,000 | -79.6% | 97,011 | -62.4% | 0.00% | -66.7% |
Q3 2018 | $9,987,000 | +11.4% | 257,982 | +13.2% | 0.00% | 0.0% |
Q2 2018 | $8,967,000 | +4129.7% | 227,897 | +2046.7% | 0.00% | – |
Q1 2018 | $212,000 | -48.3% | 10,616 | -41.4% | 0.00% | – |
Q4 2017 | $410,000 | – | 18,101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |